ANP signaling inhibits TGF-β-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells
Authors:
- Peng LiPLPeng Li
- Suzanne OparilSOSuzanne Oparil
- Lea NovakLNLea Novak
- Xu CaoXCXu Cao
- Weibin ShiWSWeibin Shi
- Jason LucasJLJason Lucas
- Yiu-Fai ChenYCYiu-Fai Chen
- 1 January 2007
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 102 (1) , 390-398
Abstract
Atrial natriuretic peptide (ANP) and transforming growth factor (TGF)-β play important counterregulatory roles in pulmonary vascular adaptation to chronic hypoxia. To define the molecular mechanism of this important interaction, we tested whether ANP-cGMP-protein kinase G (PKG) signaling inhibits TGF-β1-induced extracellular matrix (ECM) expression and defined the specific site(s) at which this molecular merging of signaling pathways occurs. Rat pulmonary arterial smooth muscle cells (PASMCs) were treated with ANP (1 μM) or cGMP (1 mM) with or without pretreatment with PKG inhibitors KT-5823 (1 μM) or Rp-8-bromo-cGMP (Rp-8-Br-cGMP 50 μM), then exposed to TGF-β1 (1 ng/ml) for 5–360 min (for pSmad nuclear translocation and protein analysis) or 24 h (for ECM mRNA expression). Nuclear translocation of pSmad2 and pSmad3 was assessed by fluorescent confocal microscopy. ANP and cGMP inhibited TGF-β1-induced pSmad2 and pSmad3 nuclear translocation and expression of periostin, osteopontin, and plasminogen activator inhibitor-1 mRNA and protein, but not TGF-β1-induced phosphorylation of Smad2 and Smad3. KT-5823 and Rp-8-Br-cGMP blocked ANP/cGMP-induced activation of PKG and inhibition of TGF-β1-stimulated nuclear translocation of pSmad2 and pSmad3 in PASMCs. These results reveal for the first time a precise site at which ANP-cGMP-PKG signaling exerts its antifibrogenic effect on the profibrogenic TGF-β1 signaling pathway: by blocking TGF-β1-induced pSmad2 and pSmad3 nuclear translocation and ECM expression in PASMCs. Blocking nuclear translocation and subsequent binding of pSmad2 and pSmad3 to TGF-β-Smad response elements in ECM genes may be responsible for the inhibitory effects of ANP on TGF-β-induced expression of ECM molecules.Keywords
This publication has 33 references indexed in Scilit:
- Smad3 phosphorylation by cyclin-dependent kinasesCytokine & Growth Factor Reviews, 2006
- Dominant negative mutation of the TGF-β receptor blocks hypoxia-induced pulmonary vascular remodelingJournal of Applied Physiology, 2006
- Current Insights on the Pathogenesis of Pulmonary Arterial HypertensionSeminars in Respiratory and Critical Care Medicine, 2005
- Identification and Characterization of ERK MAP Kinase Phosphorylation Sites in Smad3Biochemistry, 2005
- Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cellsJournal of Applied Physiology, 2004
- TGF-β induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathwaysKidney International, 2004
- The Mouse Through the Looking GlassCirculation Research, 2004
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Regulation of Smad signaling by protein kinase CThe FASEB Journal, 2001
- A mechanism of repression of TGFbeta / Smad signaling by oncogenic RasGenes & Development, 1999